Children's Dimetapp Cold & Cough Recalled for Missing Dosing Cup Graduations
Glaxosmithkline is recalling Children's Dimetapp Cold & Cough bottles because the included dosing cups are missing graduation marks for certain age groups.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, and the hazard involves a packaging/dosing defect (missing graduations) rather than a direct chemical or biological contamination, fitting the criteria for moderate severity.
Plain-English summary
Glaxosmithkline Consumer Healthcare Holdings is recalling 78,132 bottles of Children's Dimetapp Cold & Cough, 8 FL OZ. (237 mL), for ages 6 years and over. The product is distributed by Pfizer in Madison, NJ, and was made in Canada. The specific lot affected is CL8292, with an expiration date of 09/30/2021.
The recall was initiated because the dosing cups included with the product are missing graduation marks applicable to certain age groups. This defect in the delivery system may make it difficult for consumers to measure the correct dose for the intended age range.
The product was distributed nationwide in the US. Consumers should check their bottles for the specific lot number and expiration date listed above. If the product matches the recalled lot, consumers should stop using it and follow instructions from the recalling firm or their healthcare provider regarding disposal or return.
The recalled product
- Product
- Childrens Dimetapp Cold & Cough, For ages 6 yrs. & over, 8 FL OZ. bottle, (237 mL), Distributed by: Pfizer Madison, NJ 07940, Made in Canada, UPC: 60300312234196, NDC: 0031-2234-19.
- Manufacturer
- Glaxosmithkline Consumer Healthcare Holdings
- Category
- Drug — Cold & Cough
- Hazard
- Affected units
- 78,132
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot CL8292
- Exp. 09/30/2021
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 2 recalled by Glaxosmithkline Consumer Healthcare Holdings under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same manufacturer · Glaxosmithkline Consumer Healthcare Holdings
See all →- ModerateChildren's Robitussin DM Recalled for Missing Dosing Cup Graduations
FDA (Drugs) · 2020-07-08
- ModerateGaviscon Antacid Recalled for Missing Magnesium Safety Warning
FDA (Drugs) · 2020-06-24
- ModerateGaviscon Antacid Recalled for Missing Magnesium Safety Warning
FDA (Drugs) · 2020-06-24
- ModerateGaviscon Liquid Antacid Recalled for Missing Magnesium Safety Warning
FDA (Drugs) · 2020-06-24
- ModerateGaviscon Extra Strength Liquid Antacid Recalled for Missing Magnesium Warning
FDA (Drugs) · 2020-06-24
Same hazard · mis labeling
See all →- ModerateMedline Trach Tube Kit Recalled for Component Labeling Discrepancy
FDA (Devices) · 2026-09-02
- ModerateAVID Medical Recalls Halyard Total Joint Kits for Latex Labeling Deficiency
FDA (Devices) · 2026-09-02
- ModerateOlympus Recalls PowerSeal Sealer Due to Incorrect Outer Box Labeling
FDA (Devices) · 2026-09-02
- HighSura Tanmen Ramen Noodles Recalled for Undeclared Fish Allergens
FDA (Food) · 2026-09-02
- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-09-02